1.Effects of Components of Medium for Photo-synthetic Bacteria on its Synthesizing Carotenoid
De-Ming CHEN ; Yong-Bin HAN ; Zhen-Xin GU ;
Microbiology 1992;0(03):-
The medium of photo-synthetic bacteria synthesizing carotenoid was optimized with response surface methodology. The regression equation expressing the relationship between carotenoid yield and main components of culture medium was established by stepwise analysis. The R-squared in the model of regression equation was 0. 958, which meant the established equation could predict the carotenoid yield well at the range of factors in this design. It was indicated that the optimum medium components were: 0. 81% citric acid, 0. 35% NH4Cl and 0. 18% corn syrup. On those conditions, it was predicted that the highest production of carotenoid was 13. 34 mg/L, which was 2. 04 times higher than initial carotenoid yield before optimization.
2.Modified decompressive craniectomy in combination with indirect revascularization for the treatment of massive cerebral infarction
Xiaochun SHE ; Yongjun CHEN ; Zhen WANG ; Jianjun HE ; Xiaoming JIANG ; Aiming CHEN ; Jinlin LI ; De SUN
International Journal of Cerebrovascular Diseases 2009;17(12):902-907
Objective To investigate the operative methods and their efficacy of the modified decompressive craniectomy in combination with indirect revascularization for the treatment of massive cerebral infarction. Methods The clinical data of 15 patients with massive cerebral infarction who underwent modified decompressive craniectomy in combination with encephaloduroarteriomyosynangiosis were analyzed retrospectively. The clinical efficacy was assessed according to the mortality, Barthel Index and modified Rankin scale. Results All the patients were followed up, and 12 patients survived 3 months after operation, of those, 4 had a good functional outcome; 11 patients survived 6 month after operation, of those, 7 had a good functional outcome. Conclusions The modified decompressive craniectomy in combination with indirect revascularization for the treatment of massive cerebral infarction could effectively treat massive cerebral infarction and increase the survival rate and life quality of patients, however, the surgical timing, surgical indications and surgical skills are needed to master accurately.
3.The study of hematopoietic cell reaction to interleukin-15 in children with myelodysplastic syndrome
han-rong, CHENG ; ming-zhen, CHEN ; ri-ling, CHEN ; de-yuan, ZHENG ; zhong-lv, YE
Journal of Applied Clinical Pediatrics 1986;0(01):-
Objective To investigate children′s myelodysplastic hematopoietic cells reaction to interleukin (IL)-15.Methods CD 34 + cells in bone marrow from 18 myelodysplast syndrome(MDS) patients were purified by an immunomagnetic beads sorting system. Apoptosis of hematopoietic precursors was assayed by propidium iodine staining and flow cytometric analysis.Results On 8th cultured day,when IL-15 concentration was between 0-100 ng/ml,it could suppress apoptosis of hematopoietic cells in MDS patients in a dose-and- time dependent manner. IL-15 in study group significanthy lower than that of control group.Conclusion IL-15 may partly suppress apoptosis of hematopoietic cells in MDS patients.
4.Chemical constituents from Morus notabilis and their cytotoxic effect.
Pan ZHEN ; Gang NI ; Xiao-guang CHEN ; Ruo-yun CHEN ; Han-ze YANG ; De-quan YU
Acta Pharmaceutica Sinica 2015;50(5):579-582
Une new flavonoids named as notabilisin K (1), together with four known compounds, morusin (2), mulberrofuran A (3), neocyclomorusin (4) and mornigrol F (5) are separated from 95% ethanol extracts of the twigs of Morus notabilis. Compounds 2-5 are separated from this plant for the first time. Notabilisin I, notabilisin J exhibits certain effect against cells of HCT-116, HepG2 and A2780 with IC50 values ranging from 1.47 μmol x L(-1) to 5.46 μmol x L(-1). Morusin exhibits strong effect against five kinds of human cancer cells (BGC823, A2780, HCT-116, HepG2 and NCI-H1650) with IC50 values ranging from 0.74 μmol x L(-1) to 1.58 μmol x L(-1).
Antineoplastic Agents, Phytogenic
;
chemistry
;
Benzofurans
;
chemistry
;
Flavonoids
;
chemistry
;
Hep G2 Cells
;
Humans
;
Inhibitory Concentration 50
;
Morus
;
chemistry
;
Plant Extracts
;
chemistry
;
Terpenes
;
chemistry
5.A multicenter,randomized,double-blinded and placebo-controlled study of acute brain infarction treated by human urinary kallidinogenase
De-Yun DING ; Chuan-Zhen LU ; Mei-Ping DING ; Bing-Hua SU ; Feng CHEN ;
Chinese Journal of Neurology 2000;0(05):-
Objective To evaluate the efficacy and safety of a new drug,human urinary kallidinogenase,against acute brain infarction.Method A 15-center,randomized,double-blinded and 3:1 placebo-controlled study was carried out.Acute brain infarction within 48 hours of onset in the territory of the middle cerebral artery were indicated as subjects;kallidinogenase or placebo which was dissolved in 50 ml saline,was slowly injected intraveousely within 30 minutes daily for 3 weeks.The European Stroke Scale and Barthel Index were used to evaluate the neurological deficit and the activities of daily living(ADL),followed by a follow-up at the end of the third month.Results 446 patients were enrolled,who completed ITT analysis,including 330 in kallidinogenase group and 116 in placebo group,meanwhile 421 proceeded with PP analysis(311 and 110 respectively).There were no significant differences of the baseline data between the 2 groups.At the end of treatment,the ESS scores increased by 55.1%?33.0% and 44.7%?32.8% respectively in kallidinogenase group(KG)and placebo group(PG,P=0.0022),the difference being significant.PP analysis had similar results.As for ADL,follow-up 90 days after the treatment showed 374 cases followed,280 in KG and 94 in PG;1 died in PG,while none in KG.In KG,the cases whose BI≥50 were significantly more than those in PG(P=0.0228).Adverse events possibly or definitely attributable to the drug were observed in 27 cases(7.74%),mostly were mild,such as palpitation,flush,dizziness, nausea etc,without special management needed.Only 2 died which was confirmed not correlated to kallidinogenase,and another 2 cases of sudden blood pressure drop were observed.The blood pressure drop, quickly restoring soon after the withdrawal of kallidinogenase and use of hemopiesic drugs,was considered to be caused by the combination use of anti-hypertensive drug ACEI and quick infusion speed.Conclusion Kallidinogenase is efficacious for acute brain infarction in improving the neurological deficits,which is safe in clinical use.
6.Enrichment of breast cancer stem cells using a keratinocyte serum-free medium.
Zhen-Zhen LIU ; Ping CHEN ; Zhen-Duo LU ; Shu-de CUI ; Zi-Ming DONG
Chinese Medical Journal 2011;124(18):2934-2936
BACKGROUNDKeratinocyte serum-free medium (K-SFM) is a defined medium used to support the growth of primary keratinocytes and embryonic stem cell. The aim of this research was to optimize enrichment of breast cancer stem cells (CSCs) using K-SFM.
METHODSA K-SFM was used to enrich CSCs from two breast cancer cell lines and a primary culture of breast cancer. RPMI-1640 supplemented with 10% fetal calf serum (FCS) was used as a control. CSCs were identified with flow cytometry using CD44(+)/CD24(-) as molecular markers. The expression of a variety of CSC markers (Oct-4, ABCG2, Nanog, N-cadherin, and E-cadherin) was analyzed with real-time PCR.
RESULTSMuch higher percentage of CSCs was achieved with K-SFM: 17.3% for MCF-7 cells, 17.4% for SKBR-3, and 20.0% for primary breast cancer culture. Less than 1% CSC was achieved using RPMI-1640 supplemented with 10% FCS. In comparison to the CSCs obtained with RPMI-1640, CSCs in the K-SFM expressed higher levels of Oct-4, ABCG2, Nanog and N-cadherin, and lower level of E-cadherin.
CONCLUSIONK-SFM is an optimal culture medium to maintain and to enrich breast CSCs.
ATP Binding Cassette Transporter, Sub-Family G, Member 2 ; ATP-Binding Cassette Transporters ; genetics ; Cadherins ; genetics ; Cell Culture Techniques ; methods ; Cell Line, Tumor ; Culture Media, Serum-Free ; Female ; Homeodomain Proteins ; genetics ; Humans ; Keratinocytes ; cytology ; Nanog Homeobox Protein ; Neoplasm Proteins ; genetics ; Neoplastic Stem Cells ; cytology ; metabolism ; Octamer Transcription Factor-3 ; genetics ; Real-Time Polymerase Chain Reaction
7.Case Report of Peliosis Hepatic in Child and Its Literature Review
zhao-yuan, QIN ; shu-mei, CHEN ; rui-de, HU ; xiao-yun, JIANG ; mei-na, LIU ; zhen-yu, SHEN
Journal of Applied Clinical Pediatrics 2006;0(19):-
Objective To report a peliosis hepatic in child and review literature and discuss.Methods Case history was inquired.Physical,labtoratory,imagement and histopathology of liver biopsy(HE staining) were examed.Results A 4-year old girl appeared dermatitis with erythema and herpes at local skin where was bit by insect before onset.The girl appeared fever,cough,then abdominal pain,hepatomegaly,pleural effusion and ascites.Lab examination revealed slight elevation of aspartate transaminase,?-glutamyltranspeptidase and alkaline phosphatase.The liver B-mode ultrasonography and CT scan revealed hepatomegaly with density heterogeneity of the parenchyma.The liver biopsy revealed many small capsule filled with blood cells.Conclusions Clinical characteristics of the disease are fever,upper abdomen pain,janundice,ascites and hepatomegaly.The diagnosis shall be combined with the pathologic biopsy of liver.
8.Analysis of influenza surveillance from 2000 to 2007 in Gansu province.
Hong-Yu LI ; De-Shan YU ; Jian-Hua CHEN ; Xue-Zhen LIU
Chinese Journal of Experimental and Clinical Virology 2008;22(4):266-268
OBJECTIVETo study the epidemical characteristics of influenza in Gansu province from 2000 to 2007, and to discuss the changes of the predominant strains of influenza virus. This study provide scientific basis for defending influenza effectively.
METHODSInfluenza surveillance, collecting the pharyngeal swab specimens from influenza patients of national surveillance hospital and unsure influenza epidemic situations, inoculated on MDCK cell culture to obtain the influenza virus strains.
RESULTS2001.10-2007.12, collecting the 6383 specimens, 943 influenza virus strains were isolated, positive rate was 14.77%, 218 strains were A1 (H1N1 ), 352 strains were A3 (H3N2), 312 strains were B subtype of Victoria and 61 strains were B subtype of Yamagata. There were totally 61 outbreak of influenza-like cases were observed in Gansu Province during the last 5 years, 44 cases were isolated influenza virus, of 38 cases were caused by B subtype of Victoria virus strains, 3 cases were caused by H3N2, 2 cases were caused by B subtype of Yamagata virus strains, 1 cases were caused by H1N1.
CONCLUSIONInfluenza is active in human population. Influenza type A virus is predominant in winter and type B virus resulted in the outbreak in school and kidsgarden from March to June in the last 3 years.
Adolescent ; Adult ; Aged ; Animals ; Cell Line ; Child ; Child, Preschool ; China ; epidemiology ; Disease Outbreaks ; Dogs ; Female ; Humans ; Influenza A Virus, H1N1 Subtype ; isolation & purification ; Influenza A Virus, H3N2 Subtype ; isolation & purification ; Influenza A virus ; isolation & purification ; Influenza B virus ; isolation & purification ; Influenza, Human ; epidemiology ; virology ; Male ; Middle Aged ; Population Surveillance ; Seasons ; Young Adult
9.Study on enzymatic extraction process of polysaccharide from Urena lobata L.and investigation on its antioxidant activity
Shi-Hua ZHAO ; Gui-Zhen NONG ; Li-Li MENG ; Xiao-Bai CHEN ; De-Qi JIANG
Chinese Journal of Pharmacology and Toxicology 2018;32(4):341-341
OBJECTIVE This study aimed to optimize polysaccharides extraction from Urena lobata L.and investigate its antioxidant activity.METHODS The mathematical model was established by re-sponse surface method (RSM) based on the results of single factor experiments, using polysaccha-rides extraction rate as response value,and using the ratio of water to material,cellulase concentra-tion,extraction temperature and time as experimental factors,which was used to screen optimum poly-saccharide extraction conditions from Urena lobata L.. Antioxidant activity of polysaccharides was stud-ied by DPPH and ·OH free radical elimination method. RESULTS The optimum conditions obtained by RSM were as follows:the cellulase level was 10.8 g·L-1,extraction time duration was 72 min,the ra-tio of water to feedstock was 7 mL·g-1,extraction temperature was 43℃,the pH value was 5.0.Under the optimal conditions, there was a difference of less than 5% between predicted extraction rate 13.37% and experimental extraction rate 13.32%. The polysaccharide yield was most significantly af-fected by cellulase concentration,followed by extraction time,water to material ratio and extraction tem-perature.IC50of DPPH and·OH were 1.082 g·L-1and 3.202 mg·L-1,respectively.Antioxidant activity of sample polysaccharides was weaker than those of vitamin C. CONCLUSION The polysaccharide extraction process from Urena lobata L. by cellulase enzymolysis approach was obtained, which was convenient and feasible,and extracted polysaccharides had good free radical scavenging activity.
10.Multicenter research on efficacy and tolerance of memantine in Chinese patients with Alzheimer's disease
Xia CHEN ; Zhen-Xin ZHANG ; Xin-De WANG ; Jing-Li YAO ; Sheng-Di CHEN ; Cai-Yun QIAN ; Shi-Fu XIAO ; Liang SHU ; Hong-chuan TANG
Chinese Journal of Neurology 1999;0(06):-
Objective To evaluate the efficacy and safety of memantine in the treatment of patients with Alzheimer' s disease (AD).Methods This was a 16-week,multi-center,randomized,double blind, placebo-controlled clinical trial (Study 10116).A total of 258 AD patients (MMSE score 5—18) were randomized in a 1:1 ratio into either memantine 10—20 mg/day (MEM,n=128) or placebo (PBO,n= 130) group for 16 weeks.Efficacy was primarily assessed in terms of changes of severe impairment battery (SIB) score in patients from baseline up to SIB assessment in the 16th week (16-week completers set, CS16).While ehanges of MMSE,ADCS-ADL_(19),and NPI (neuropsychiatric inventory) were evaluated as secondary efficacy parameters on both CSI6 and full-analysis set (FAS).Safety was assessed by physical examination,lab assays,ECG,and adverse events.Results 236 subjeets (CS16:MEM n=117,PBO n=119) were eligible for the efficacy assessment.No statistically significant difference between the treatments was observed on the primary and seeondary efficacy analysis,although both treatment groups had a slight increase from baseline in SIB total score.Post hoe evaluation of the data identified two bias factors that had a significant impact on the results of the pre-protoeol specified primary and secondary analyses.In a re-analysis of the data (CS16_(modified),MEM n=94,PBO n=95) excluding patient data affeeted by these factors,memantine-treated patients showed a statistically significant improvement related to placebo in the 16th week on the SIB (MEM 2.2 vs PBO 0.3,P=0.04),MMSE (MEM 1.0 vs PBO 0.1,P=0.03),and ADL (MEM 0.1 vs PBO-1.6,P=0.02) scales,indicating that memantine improved the cognitive function of AD patients and stabilized the activity of daily life.Memantine was well tolerated with an adverse event profile similar to that of placebo.Conclusion This study provides further support for pre-existing data,showing that memantine is efficacious,safe,and well-tolerated in patients with moderate to severe AD.